Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ramos

Showing results (591-600 of 606) with videos related to

Pageof 61
Sort By:
Parasitology|January 21, 2022
Diagnostic application of sensitive and specific phage-exposed epitopes for visceral leishmaniasis and human immunodeficiency virus coinfectionFernanda F Ramos, Grasiele S V Tavares, Fernanda Ludolf, et al.
Parasitology Research|June 15, 2020
Evaluation of the protective efficacy of a Leishmania protein associated with distinct adjuvants against visceral leishmaniasis and in vitro immunogenicity in human cellsPatrícia A F Ribeiro, Daniel S Dias, Daniela P Lage, et al.
Microbial Pathogenesis|January 24, 2021
Leishmania eukaryotic elongation Factor-1 beta protein is immunogenic and induces parasitological protection in mice against Leishmania infantum infectionThaís T O Santos, Amanda S Machado, Fernanda F Ramos, et al.
Advances in Therapy|November 28, 2025
Comparative Efficacy of Talquetamab vs. Real-World Physician's Choice of Treatment in Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma: Updated Analyses of MonumenTAL-1 vs. LocoMMotion/MoMMentHermann Einsele, Philippe Moreau, Nizar Bahlis, et al.
Molecular Immunology|October 9, 2017
Recombinant small glutamine-rich tetratricopeptide repeat-containing protein of Leishmania infantum: Potential vaccine and diagnostic application against visceral leishmaniasisDaniel S Dias, Patrícia A F Ribeiro, Vívian T Martins, et al.
Parasitology Research|November 16, 2020
Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasisCamila S Freitas, João A Oliveira-da-Silva, Daniela P Lage, et al.
The Journal of Infectious Diseases|September 27, 2024
Rare Genetic Variants of NLRP12 in Admixed Latino-American Children With SARS-CoV-2-Related Multisystem Inflammatory SyndromeThaís M M Barreto, Roberta S Souza, Raquel B São Pedro, et al.
Parasite Immunology|August 11, 2020
Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasisIsabela A G Pereira, Débora V C Mendonça, Grasiele S V Tavares, et al.
Annals of Hematology|June 17, 2024
Do NPM1 and FLT3-ITD mutations modify prognosis in patients treated with non-intensive regimens?E U Suárez, B Boluda, E Lavilla, et al.
Viruses|April 30, 2021
The Microcephaly Epidemic Research Group Paediatric Cohort (MERG-PC): A Cohort ProfileDemócrito de Barros Miranda-Filho, Elizabeth B Brickley, Anna Ramond, et al.
Pageof 61

Showing results (591-600 of 606) with videos related to

Sort By:
Pageof 61
Parasitology|January 21, 2022
Diagnostic application of sensitive and specific phage-exposed epitopes for visceral leishmaniasis and human immunodeficiency virus coinfectionFernanda F Ramos, Grasiele S V Tavares, Fernanda Ludolf, et al.
Parasitology Research|June 15, 2020
Evaluation of the protective efficacy of a Leishmania protein associated with distinct adjuvants against visceral leishmaniasis and in vitro immunogenicity in human cellsPatrícia A F Ribeiro, Daniel S Dias, Daniela P Lage, et al.
Microbial Pathogenesis|January 24, 2021
Leishmania eukaryotic elongation Factor-1 beta protein is immunogenic and induces parasitological protection in mice against Leishmania infantum infectionThaís T O Santos, Amanda S Machado, Fernanda F Ramos, et al.
Advances in Therapy|November 28, 2025
Comparative Efficacy of Talquetamab vs. Real-World Physician's Choice of Treatment in Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma: Updated Analyses of MonumenTAL-1 vs. LocoMMotion/MoMMentHermann Einsele, Philippe Moreau, Nizar Bahlis, et al.
Molecular Immunology|October 9, 2017
Recombinant small glutamine-rich tetratricopeptide repeat-containing protein of Leishmania infantum: Potential vaccine and diagnostic application against visceral leishmaniasisDaniel S Dias, Patrícia A F Ribeiro, Vívian T Martins, et al.
Parasitology Research|November 16, 2020
Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasisCamila S Freitas, João A Oliveira-da-Silva, Daniela P Lage, et al.
The Journal of Infectious Diseases|September 27, 2024
Rare Genetic Variants of NLRP12 in Admixed Latino-American Children With SARS-CoV-2-Related Multisystem Inflammatory SyndromeThaís M M Barreto, Roberta S Souza, Raquel B São Pedro, et al.
Parasite Immunology|August 11, 2020
Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasisIsabela A G Pereira, Débora V C Mendonça, Grasiele S V Tavares, et al.
Annals of Hematology|June 17, 2024
Do NPM1 and FLT3-ITD mutations modify prognosis in patients treated with non-intensive regimens?E U Suárez, B Boluda, E Lavilla, et al.
Viruses|April 30, 2021
The Microcephaly Epidemic Research Group Paediatric Cohort (MERG-PC): A Cohort ProfileDemócrito de Barros Miranda-Filho, Elizabeth B Brickley, Anna Ramond, et al.
Pageof 61